23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.01%
Positive revenue growth while Insurance - Life median is negative. Peter Lynch might see a relative strength advantage in a tough sector.
5.01%
Gross profit growth of 5.01% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that could be built upon.
-66.92%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-66.92%
Negative operating income growth while Insurance - Life median is -3.69%. Seth Klarman would check if structural or cyclical issues are at play.
-83.21%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-83.19%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-83.21%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.07%
Negative OCF growth while Insurance - Life median is 3.05%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-16.07%
Negative FCF growth while Insurance - Life median is 1.66%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-31.10%
Negative 10Y revenue/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
27.25%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 16.66%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
-19.21%
Negative 3Y CAGR while Insurance - Life median is 2.55%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
73.99%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 27.64% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
183.25%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 34.53%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
16.45%
3Y OCF/share growth near Insurance - Life median. Charlie Munger would find it typical for industry-level short-term expansions.
116.36%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
-77.25%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
39.73%
3Y net income/share CAGR > 1.5x Insurance - Life median of 24.03%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
68.14%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
60.72%
5Y equity/share CAGR > 1.5x Insurance - Life median of 39.72%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
11.40%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.40%
AR growth of 10.40% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
0.33%
We expand assets while Insurance - Life is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
3.66%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
0.99%
Debt growth of 0.99% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
17.49%
SG&A growth of 17.49% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.